ANTITUMOR EFFICACY OF PEPTIDE RECEPTOR RADIONUCLIDE THERAPY WITH 177LUTETIUM -OCTREOTATE RANDOMIZED VS SUNITINIB IN UNRESECTABLE PROGRESSIVE WELL-DIFFERENTIATED NEUROENDOCRINE PANCREATIC TUMOR: FIRST RANDOMIZED PHASE II: